Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium fluoride + carbopol** is a combination of **sodium fluoride**, an inorganic fluoride salt used primarily for caries prevention, and **carbopol**, a synthetic high-molecular-weight crosslinked polymer of acrylic acid used as a gel-forming and bioadhesive excipient in pharmaceutical formulations. Sodium fluoride promotes tooth enamel remineralization and inhibits demineralization by forming fluorapatite, which is more acid-resistant than hydroxyapatite, and may also exert antibacterial effects by interfering with bacterial metabolism and acid production. Carbopol acts mainly as a bioadhesive and viscosity modifier; in oral or topical formulations it can enhance the retention of sodium fluoride on tooth/enamel or mucosal surfaces, optimizing the pharmacodynamic effect and improving the protective and remineralizing potential of the fluoride by increasing its contact time with tissues. This combination is most commonly used in dental products such as mouth rinses, gels, or toothpaste designed for anti-caries and anti-erosive effects[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + carbopol.